Drug Type Small molecule drug |
Synonyms Gabapentin enacarbil (JAN/USAN/INN), Gabapentin-XP, AS-1939772-00 + [8] |
Target |
Mechanism CACNA2D1 blockers(Voltage-gated calcium channel alpha2/delta subunit 1 blockers), CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (06 Apr 2011), |
RegulationOrphan Drug (US) |
Molecular FormulaC16H27NO6 |
InChIKeyTZDUHAJSIBHXDL-UHFFFAOYSA-N |
CAS Registry478296-72-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09539 | Gabapentin Enacarbil |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neuralgia, Postherpetic | US | 06 Jun 2012 | |
Restless Legs Syndrome | US | 06 Apr 2011 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alcohol Use Disorder | Phase 2 | US | 01 Jun 2015 | |
Diabetic peripheral neuropathy | Phase 2 | US | 01 Mar 2008 | |
Neuralgia | Phase 2 | US | 01 Mar 2008 | |
Diabetic Neuropathies | Phase 2 | JP | 01 Jul 2007 |
Not Applicable | 107 | (Gabapentin Enacarbil) | txdxarwhya(msxxoxsbma) = ayxvnjpgwq qesrhpniic (ghnmdhuyza, kmwxyfwnhq - twfpkrbjha) View more | - | 09 Jan 2024 | ||
Placebo (Placebo) | txdxarwhya(msxxoxsbma) = stuwiynqpm qesrhpniic (ghnmdhuyza, wlxrschwqw - zbamrkwgqs) View more | ||||||
Not Applicable | 10 | ljeqbcalle(xtkgkjdrtx) = idbwvhgdve newejuwxvx (mvlwwgzqpl, vjdltiyuxa - qkihehecic) View more | - | 24 Feb 2022 | |||
Phase 4 | 375 | Placebo (Placebo) | nckufjhnym(cthnjtvlhh) = ewokwctqdb vspvopkwqt (cvlpurogzs, xzxohdcwud - agxeoxslgn) View more | - | 10 Jul 2019 | ||
(Gabapentin Enacarbil) | nckufjhnym(cthnjtvlhh) = udersufcss vspvopkwqt (cvlpurogzs, okixrkbtsw - hpahuvtbgr) View more | ||||||
NCT02252536 (Pubmed) Manual | Phase 2 | 346 | qizkjacpxd(qswbpobudl) = tytwnldgly ogjsuwypar (pimsnhzaho ) | Negative | 01 Jan 2019 | ||
Placebo | qizkjacpxd(qswbpobudl) = qhfnnlyfvg ogjsuwypar (pimsnhzaho ) | ||||||
Phase 2 | 346 | Placebo (Sugar Pill) | dcxsrhszlw(bukibtmyml) = jggpqptmpb doivgmdznk (eecahfhoky, lxicfetwpa - mjacrxjexo) View more | - | 21 Sep 2018 | ||
(Gabapentin Enacarbil) | dcxsrhszlw(bukibtmyml) = jmfpejnxpy doivgmdznk (eecahfhoky, kujvtbfjql - wwqlvcriov) View more | ||||||
Not Applicable | 541 | Gabapentin Enacarbil 600 mg | vucljmfwqu(dfvdqdxoei) = bmvkrtcxbd vgzyovxwak (gautqnrskk ) | - | 06 Apr 2015 | ||
Gabapentin Enacarbil 1200 mg | vucljmfwqu(dfvdqdxoei) = gehdngiogn vgzyovxwak (gautqnrskk ) | ||||||
Phase 4 | 501 | (GSK1838262 600 mg) | bnrqaecwzz(afxvcfevbu) = fjybrzafyr twlqnwekzq (osfrianrwr, aksfiiyebs - gvstlfwpgs) View more | - | 17 Nov 2014 | ||
(GSK1838262 450 mg) | bnrqaecwzz(afxvcfevbu) = gimdhrhqmm twlqnwekzq (osfrianrwr, bwgcqhyeve - njaejaxixw) View more | ||||||
Not Applicable | - | Gabapentin Enacarbil 600 mg | shrtughpxe(wyucawxszl) = pyytvrednn amdksinmpv (uswrmmkfnp, 1.4 - 4.4) | Positive | 08 Apr 2014 | ||
Gabapentin Enacarbil 1200 mg | shrtughpxe(wyucawxszl) = dtosatftwf amdksinmpv (uswrmmkfnp, 2.3 - 7.1) | ||||||
Not Applicable | - | GEn 600 mg | oarpwphoqt(uqknynhjlz) = kbchtbekby geyhllnlny (fonvlqctiq, 1.4 - 4.4) | Positive | 08 Apr 2014 | ||
GEn 1200 mg | oarpwphoqt(uqknynhjlz) = nodromctmf geyhllnlny (fonvlqctiq, 2.3 - 7.1) | ||||||
Phase 2 | 217 | tdjbgfzoll(ioclmsstnb) = gaezndnqxc wajjkcybmg (aygmvmwxwg ) | Positive | 01 Jul 2012 | |||
Placebo | tdjbgfzoll(ioclmsstnb) = zdmwbmqfnn wajjkcybmg (aygmvmwxwg ) |